XM does not provide services to residents of the United States of America.

Here's why SocGen think USD/CHF topside options are cheap



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-COMMENT-Here's why SocGen think USD/CHF topside options are cheap</title></head><body>

Sept 4 (Reuters) -Societe Generale advocates an option trade that would benefit from USD/CHF gains, with their rationale being that CHF does not reflect dovish SNB pricing.

The biggest central bank repricing over the last month was bySwitzerland, with the Swiss interest rate for December seen 25bps lower than it was a month ago - a bigger dovish repricing than for U.S. rates. Meanwhile, the CHF gained more than 1% versus USD over this period as the market unwound short CHF carry trades. In this context, Societe Generale say that in their view, the relative strength of CHF does not yet reflect either the significant dovish SNB pricing or market expectations.

Switzerland's Q2 GDP growth delivered a positive surprise this week, but August headline (and core) CPI printed at only 1.1%, fuelling dovish expectations. The market remains essentially driven by rates, and USD/CHF is indeed tracking its short rates differential. The latter is bottoming out at the same level as in January, when a bounce was followed by a multi-month USD/CHF uptrend. Societe Generale therefore now see greater USD/CHF upside risk.

The bank notes that USD/CHF realised volatility has risen faster than implied volatility, which creates a negative volatility risk premium that cheapens USD/CHF options. At the same time the volatility premium for CHF calls over puts increased as the USD depreciated and the CHF gained, so there is a discount for topside USDCHF strikes, too.

Societe Generale suggests a 2-month expiry 0.8730 CHF put/USD call strike with an indicative offer of 0.25% with USD/CHF spot at 0.8500. The strike is set at the mid August peak and assumes a move toward and beyond this level. If the USD/CHF fails to rise, the maximum loss is the premium paid.


For more click on FXBUZ












USD/CHF 2-month FXO implied vs historic/ realised volatility https://tmsnrt.rs/47g59Lr

USD/CHF 2-month expiry FXO risk reversals https://tmsnrt.rs/3TfyujF

(Richard Pace is a Reuters market analyst. The views expressed are his own)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.